{"filing":{"accession_number":"0001178913-26-004808","cik":"0001553846","ticker":"RDHL","company_name":"RedHill Biopharma Ltd.","form":"6-K","filing_date":"2026-10-21","report_date":"2026-10-21","primary_document":"zk2636244.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1553846/000117891326004808/zk2636244.htm"},"events":[{"id":36575,"run_id":33722,"accession_number":"0001178913-26-004808","anchor_item_number":null,"event_type":"financial_other","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"RedHill regained ex-North America rights to RHB-102 through termination of a licensing agreement with Hyloris, receiving a $200,000 break-up fee and recovering full worldwide rights to the asset. This is a material financial and strategic event involving recovery of intellectual property rights and a cash payment, but does not fit the specific categories of M\u0026A activity, debt issuance, or other named financial events. The restoration of full worldwide development rights to a late-stage oncology asset is material to investor assessment of the company's pipeline and strategic position.","company_name":"RedHill Biopharma Ltd.","ticker":"RDHL","filing_date":"2026-10-21","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":41034,"accession_number":"0001178913-26-004808","item_number":null,"item_title":null,"event_type":"financial_other","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"RedHill regained ex-North America rights to RHB-102 through termination of a licensing agreement with Hyloris, receiving a $200,000 break-up fee and recovering full worldwide rights to the asset. This is a material financial and strategic event involving recovery of intellectual property rights and a cash payment, but does not fit the specific categories of M\u0026A activity, debt issuance, or other named financial events. The restoration of full worldwide development rights to a late-stage oncology asset is material to investor assessment of the company's pipeline and strategic position.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-21T11:01:36.774783+00:00","company_name":"RedHill Biopharma Ltd.","ticker":"RDHL","filing_date":"2026-10-21"}]}